63629-2068 NDC - IMATINIB MESYLATE

Drug Information

Product NDC: 63629-2068

Proprietary Name: IMATINIB MESYLATE

Non Proprietary Name: IMATINIB MESYLATE

Active Ingredient(s):
  • 400 mg/1 IMATINIB MESYLATE


Administration Route(s): ORAL

Dosage Form(s): TABLET, COATED

Pharmacy Class(es):
  • Bcr-Abl Tyrosine Kinase Inhibitors [MoA];
  • Cytochrome P450 2D6 Inhibitors [MoA];
  • Cytochrome P450 3A4 Inhibitors [MoA];
  • Kinase Inhibitor [EPC]

Labeler Information

Labeler Name: Bryant Ranch Prepack
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA205990
Marketing Category: ANDA
Start Marketing Date:2/8/2019
End Marketing Date:6/30/2023

Package Information

No. Package Code Package Description Billing Unit
163629-2068-130 TABLET, COATED in 1 BOTTLE (63629-2068-1)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC63629-2068The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEIMATINIB MESYLATEThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEIMATINIB MESYLATEThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMETABLET, COATEDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE2/8/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE6/30/2023This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEANDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERANDA205990This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEBryant Ranch PrepackName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEIMATINIB MESYLATEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH400 
ACTIVE INGRED UNITmg/1 
PHARM CLASSESBcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023